This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.
The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes: 1. HeroTracker sensor that counts dosage and monitors real-time medication adherence 2. BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
104
BreatheSmart is a comprehensive asthma monitoring system that combines a medical device and mobile application that are designed for use with Apple and Android mobile devices. The medical device connects to the mobile application using Bluetooth to facilitate the collection of controlled medication adherence, rescue medication usage, and asthma control.
Cohero Health, Inc.
New York, New York, United States
Change in asthma control
Determine change in the asthma control test (ACT), a validated asthma test, in subjects using the BreatheSmart system from baseline to 3 months.
Time frame: 3 months
Change in rescue medication usage
Determine change in rescue medication usage in subjects the BreatheSmart system from baseline to 3 months.
Time frame: 3 months
Change in controller medication adherence
Obtain medication adherence percentage (that ranges from 0-100%) to asthma inhaled corticosteroids (ICS) at baseline to 3 months.
Time frame: 3 months
Acceptability of BreatheSmart system
Acceptability questionnaire (delivered through the BreatheSmart mobile application) that includes subjects' opinion on the platform, features, usability, and usefulness.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.